Natural Capsules Ltd. AGM Voting Results: All Resolutions Passed Unanimously
Natural Capsules Limited's 33rd AGM on August 12, 2026, resulted in all six resolutions being passed with overwhelming majority. Key approvals included the FY26 financial statements, re-appointment of directors Mrs. Jyoti Mundra and Mr. Laxminarayan Moondra, and revised remuneration for Mr. Laxminarayana Moondra and Mr. Shrey Mundra.
The approval of financial statements and director re-appointments are routine but important for corporate governance. The approval of related party transactions and remuneration revisions also signifies normal business operations.
All resolutions were passed with a very high percentage of votes in favour, indicating strong shareholder confidence and support for the company's decisions.
Natural Capsules Limited has announced the voting results of its 33rd Annual General Meeting (AGM) held on August 12, 2026. The meeting, conducted via Video Conferencing (VC) or Other Audio Visual Means (OAVM), saw overwhelming support for all proposed resolutions.
The shareholders approved the adoption of the Audited Consolidated and Standalone Financial Statements for the Financial Year ended March 31, 2026, with 99.9965% of votes in favour. Additionally, resolutions for the re-appointment of directors Mrs. Jyoti Mundra and Mr. Laxminarayan Moondra were passed with 99.9958% and 99.9955% of votes in favour, respectively.
Further, the shareholders approved the re-appointment of Shri Laxminarayana Moondra as Whole-time Director for a term of 3 years, along with a revision of his remuneration, receiving 99.9942% of votes in favour. The AGM also saw approval for related party transactions with subsidiary Natural Biogenex Private Limited (99.9947% in favour) and the revision in remuneration of Mr. Shrey Mundra, General Manager Marketing (99.9933% in favour).
The e-voting facility was available from August 8, 2026, to August 11, 2026. The voting results were unblocked on August 12, 2026, after the conclusion of the AGM.
What to do with a filing like this
Natural Capsules Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Natural Capsules Limited. Read the original for the full detail.